Results 201 to 210 of about 112,363 (272)

Antibody Responses are Sustained 2 Years Post-Mpox Infection but not Following Modified Vaccinia Ankara-Bavarian Nordic Vaccination. [PDF]

Open Forum Infect Dis
Byrne J, Garcia-Leon A, Murphy A, Saini G, Banik I, Landay A, Luong Nguyen LB, Savinelli S, O'Broin C, Horgan M, Kelly C, Mejia-Chew C, Sadlier C, de Barra E, O'Halloran JA, Gautier V, Mallon PWG, Feeney ER.   +17 more
europepmc   +1 more source

Aceso: Journal of the Boston University School of Medicine Historical Society [PDF]

, 2014
Barnet, Alison, Brust, James S., Cooper, Avraham Z., Ettien, A'Llyn, Eversole, Theodore, Leach, Robert, Otlans, Peters, Paul, Richard G., Roberts, David H., Rotz, Philip D., Wells, David   +10 more
core   +1 more source

Participation of the public in global smallpox eradication.

, 1978
Foster So
openalex   +1 more source

Comparative evaluation of knowledge, attitudes and hesitancies related to four different types of vaccines: Smallpox, influenza, tetanus versus Covid-19 vaccines

Mümtaz Güran, İdil Yaren Cangert, Gamze Sabah, Ahmet Çalışkan, Kübra Çakan, Mehmet Erhan Derin, Mehmet Zana Erdoğan   +6 more
openalex   +2 more sources

Pro-inflammatory cytokine profiles and neutralizing antibodies in JYNNEOS-vaccinated and mpox-diagnosed individuals. [PDF]

NPJ Vaccines
Maciel MSC, de Souza Andrade A, Neri de Oliveira AL, Arias NEC, de Carvalho SH, Xavier MAP, Kroon EG, Campos MA.   +7 more
europepmc   +1 more source

Diagnostic Advances and Public Health Challenges for Monkeypox Virus: Clade-Specific Insight and the Urgent Need for Rapid Testing in Africa. [PDF]

Diagnostics (Basel)
Sambo CN, Skepu A, Nxumalo NP, Polori KL.   +3 more
europepmc   +1 more source

Potential of MRNA vaccines for mpox prevention: current evidence and future directions. [PDF]

Ann Med Surg (Lond)
Abdul-Rahman T, Faith OE, Ajetunmobi OA, Thaalibi HI, Ikele CG, Gautam G, Omotayo FO, Roy P, Adebayo AA, Mojeed MA, Kareem TT, Ali HI, Atieno RG, Ademeta EO, Garg N, Ashinze P, Scott GY.   +16 more
europepmc   +1 more source

Screening for asymptomatic mpox in at-risk populations: A cross-sectional study. [PDF]

PLoS One
Armenteros-Yeguas I, Homen R, Valls A, Dans L, Orviz E, Ayerdi O, Puerta T, Vera M, Pérez-García JA, Torres M, Coiras M, Del Romero J, Estrada V.   +12 more
europepmc   +1 more source

From neglected to notoriety: a review of Mpox clinical features, virology, epidemiology, treatment and prevention strategies. [PDF]

Eur J Clin Microbiol Infect Dis
Viguier C, Delobel P, Lescure FX, Bessis S, Mansuy JM, Martin-Blondel G.   +5 more
europepmc   +1 more source